Medicup logoMedicup
← Back to Blog & News

Industry News

A Common Steroid Is the First Drug Shown to Reduce COVID-19 Mortality

via World Health Organization2 min read
COVID-19DexamethasoneTreatmentTelehealthDigital HealthWHOClinical Trial
A Common Steroid Is the First Drug Shown to Reduce COVID-19 Mortality

In the global fight against COVID-19, a significant breakthrough has emerged from an unexpected place: a common, low-cost steroid.

Initial findings from a major clinical trial in the United Kingdom show that dexamethasone, a corticosteroid used to reduce inflammation, can be lifesaving for patients critically ill with the virus. The World Health Organization (WHO) is welcoming the preliminary results, which represent a major step forward in treating the most severe cases.

According to the data shared with the WHO, the benefits are specific and substantial:

  • For patients on ventilators, the treatment reduced mortality by approximately one-third.
  • For patients who required only oxygen support, mortality was cut by about one-fifth.

Crucially, the benefit was only observed in patients with severe COVID-19. The trial found no improvement for individuals with milder symptoms who did not require respiratory support. This makes dexamethasone the first treatment shown to reduce mortality in critically ill COVID-19 patients.

What This Means for Digital Health

While this is incredible news for hospital-based critical care, it also sharpens the focus on the role of telehealth in managing the full spectrum of the disease. The key takeaway is that this treatment is for the severely ill, reinforcing the need to keep milder cases from progressing and overwhelming hospitals.

This is where digital health platforms like Medicup are essential. By providing accessible virtual care, we empower providers to:

1. Triage effectively: Telehealth allows for the early assessment and monitoring of patients with mild to moderate symptoms from the safety of their homes.

2. Preserve hospital resources: By managing non-critical cases remotely, providers help ensure that hospital beds, ventilators, and now, treatments like dexamethasone, are available for those who need them most.

3. Provide continuous care: For patients recovering at home, digital tools offer a vital link to their care team, ensuring any change in condition is caught and addressed quickly.

This breakthrough in critical care doesn't replace the need for robust, accessible primary care—it makes it more important than ever. A strong digital health infrastructure is the frontline defense that helps manage the majority of cases, allowing hospital teams to focus their powerful new tools on saving the most vulnerable patients.

Source: World Health Organization

Originally reported by World Health Organization. This summary and Medicup's perspective are written independently.